Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | EXPE | Common Stock | Sale | -$58.8K | -300 | -0.1% | $195.94 | 302K | Mar 1, 2022 | Direct | F1 |
transaction | EXPE | Common Stock | Sale | -$116K | -600 | -0.2% | $192.67 | 301K | Mar 1, 2022 | Direct | F1, F2 |
transaction | EXPE | Common Stock | Sale | -$194K | -1K | -0.33% | $194.18 | 300K | Mar 1, 2022 | Direct | F1, F3 |
transaction | EXPE | Common Stock | Sale | -$211K | -1.1K | -0.37% | $191.77 | 299K | Mar 1, 2022 | Direct | F1, F4 |
transaction | EXPE | Common Stock | Sale | -$247K | -1.32K | -0.44% | $186.66 | 298K | Mar 1, 2022 | Direct | F1, F5 |
transaction | EXPE | Common Stock | Sale | -$403K | -2.12K | -0.71% | $189.55 | 296K | Mar 1, 2022 | Direct | F1, F6 |
transaction | EXPE | Common Stock | Sale | -$411K | -2.16K | -0.73% | $190.54 | 294K | Mar 1, 2022 | Direct | F1, F7 |
transaction | EXPE | Common Stock | Sale | -$452K | -2.4K | -0.82% | $188.42 | 291K | Mar 1, 2022 | Direct | F1, F8 |
transaction | EXPE | Common Stock | Sale | -$749K | -4K | -1.37% | $187.51 | 287K | Mar 1, 2022 | Direct | F1, F9 |
holding | EXPE | Common Stock | 21.9K | Mar 1, 2022 | By Children's Trust | F10 |
Id | Content |
---|---|
F1 | The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Khosrowshahi on December 1, 2021. |
F2 | The price in Column 4 is a weighted average sale price. The prices actually received ranged from $192.41 to $192.97. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
F3 | The price in Column 4 is a weighted average sale price. The prices actually received ranged from $193.65 to $194.48. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
F4 | The price in Column 4 is a weighted average sale price. The prices actually received ranged from $191.20 to $192.18. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
F5 | The price in Column 4 is a weighted average sale price. The prices actually received ranged from $186.07 to $187.04. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
F6 | The price in Column 4 is a weighted average sale price. The prices actually received ranged from $189.15 to $190.13. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
F7 | The price in Column 4 is a weighted average sale price. The prices actually received ranged from $190.18 to $191.13. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
F8 | The price in Column 4 is a weighted average sale price. The prices actually received ranged from $188.07 to $188.99. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
F9 | The price in Column 4 is a weighted average sale price. The prices actually received ranged from $187.07 to $188.06. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. |
F10 | The reporting person disclaims beneficial ownership of these shares. |